Submit Your Feeds

Business News • PR NewsWire • Cardio3 BioSciences Announces Significant Progress in its Programme for the Treatment of Acute Myocardial Infarction

Cardio3 BioSciences Announces Significant Progress in its Programme for the Treatment of Acute Myocardial Infarction
Cardio3 BioSciences Announces Significant Progress in its Programme for the Treatment of Acute Myocardial Infarction

MONT-SAINT-GUIBERT, Belgium, December 20, 2010 /PRNewswire/ -- - Pre-Clinical Results Show 70% Reduction in Infarct Size The Belgian biotechnology company, Cardio3 BioSciences, a leader in the discovery and development of regenerative and protective therapies for the treatment of cardi

View More : http://www.prnewswire.com/news-releases/cardio3-biosciences-announces-significant-progress-in-its-programme-for-the-trea...
Releted News by prnewswire
Galaxy Entertainment Group Announces Successful Closing of Upsized RMB Bond Issuance
Cardio3 BioSciences Announces Significant Progress in its Programme for the Treatment of Acute Myocardial Infarction
West-End Handbag Heaven Offers Last Minute Christmas Bargains
Over 60 digital trade shows being launched by Global Sources
Home Sitemap Contact Us
© businessNewsNewsNews.com